Spero Therapeutics, Inc. (SPRO)
1.215
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Total Assets (Quarterly) : 52.77M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.77M |
| March 31, 2026 | 59.02M |
| December 31, 2025 | 68.92M |
| September 30, 2025 | 54.17M |
| June 30, 2025 | 62.12M |
| March 31, 2025 | 77.71M |
| December 31, 2024 | 110.54M |
| September 30, 2024 | 135.16M |
| June 30, 2024 | 149.88M |
| March 31, 2024 | 167.70M |
| December 31, 2023 | 182.39M |
| September 30, 2023 | 107.10M |
| June 30, 2023 | 98.88M |
| March 31, 2023 | 112.55M |
| December 31, 2022 | 124.80M |
| September 30, 2022 | 64.48M |
| June 30, 2022 | 63.63M |
| March 31, 2022 | 145.83M |
| Date | Value |
|---|---|
| December 31, 2021 | 171.07M |
| September 30, 2021 | 144.69M |
| June 30, 2021 | 119.59M |
| March 31, 2021 | 143.44M |
| December 31, 2020 | 153.45M |
| September 30, 2020 | 157.04M |
| June 30, 2020 | 97.54M |
| March 31, 2020 | 109.89M |
| December 31, 2019 | 106.10M |
| September 30, 2019 | 112.51M |
| June 30, 2019 | 122.49M |
| March 31, 2019 | 124.65M |
| December 31, 2018 | 129.01M |
| September 30, 2018 | 136.12M |
| June 30, 2018 | 72.59M |
| March 31, 2018 | 81.06M |
| December 31, 2017 | 93.48M |
| September 30, 2017 | 31.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 49.39M |
| Fortress Biotech, Inc. | 316.72M |
| Kura Oncology, Inc. | 587.79M |
| Legend Biotech Corp. | 1.751B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.562M |
| Shareholders Equity (Quarterly) | 44.20M |
| Debt to Equity Ratio | 0.0462 |
| Current Ratio | 6.121 |
| Net Debt Paydown Yield | 0.30% |